BioInvent International AB (publ) (LON:0H22)
London · Delayed Price · Currency is GBP · Price in SEK 29.73
+0.13 (0.42%)
At close: Sep 12, 2025
LON:0H22 Market Cap
LON:0H22 has a market cap or net worth of 160.58 million as of September 18, 2025. Its market cap has decreased by -8.47% in one year.
Market Cap
160.58M
Enterprise Value
98.62M
Revenue
19.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.73
Market Cap Chart
Since June 14, 2001, LON:0H22's market cap has increased from 80.35M to 160.58M, an increase of 99.86%. That is a compound annual growth rate of 2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 160.58M | -12.39% |
| Dec 30, 2024 | 183.30M | 88.74% |
| Dec 29, 2023 | 97.12M | -41.42% |
| Dec 30, 2022 | 165.78M | -25.08% |
| Dec 30, 2021 | 221.27M | 40.59% |
| Dec 30, 2020 | 157.38M | 214.27% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 176.72B |
| GSK plc | 59.31B |
| Haleon | 30.58B |
| Smith & Nephew | 11.87B |
| ConvaTec Group | 4.76B |
| Hikma Pharmaceuticals | 3.60B |
| HUTCHMED (China) | 2.18B |
| Genus | 1.66B |